Aarti Pharmalabs Limited (BOM:543748)

Market Cap	65.41B
Revenue (ttm)	19.06B
Net Income (ttm)	2.40B
Shares Out	n/a
EPS (ttm)	26.44
PE Ratio	27.28
Forward PE	n/a
Dividend	5.00 (0.69%)
Ex-Dividend Date	Sep 15, 2025

Volume	43,883
Average Volume	21,908
Open	708.50
Previous Close	708.50
Day's Range	705.00 - 725.50
52-Week Range	550.25 - 971.50
Beta	n/a
RSI	43.28
Earnings Date	Oct 28, 2025

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,162
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In 2024, Aarti Pharmalabs's revenue was 21.15 billion, an increase of 14.17% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.